However, certainty data were not available for PPMI, and abnormal dopamine transporter scans cannot differentiate between PD and other degenerative parkinsonian conditions.52 Despite this, our sensitivity analysis suggest that our results are not being driven by non-PD conditions. This evidence concerns the gene SLC6A3 and Parkinson disease.